Inventor · disambiguated record
Scott Ogg
Also filed as: OGG SCOTT
10 granted patents·4 pending applications·97 citations·filing 1997–2017
89Inventor score
Top patents by PatentIndex Score
14 records- 0194US8461303B2LOX and LOXL2 inhibitors and uses thereofSMITH VICTORIA·Filed 2008·Granted Jun 11, 2013·30 cites·30 claims
- 0293US8658167B2Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2012·Granted Feb 25, 2014·19 cites·30 claims
- 0392US9176139B2LOX and LOXL2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2013·Granted Nov 3, 2015·16 cites·60 claims
- 0486US8679485B2Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisSMITH VICTORIA·Filed 2008·Granted Mar 25, 2014·6 cites·44 claims
- 0565US7041437B2Therapeutic and diagnostic tools for impaired glucose tolerance conditionsGEN HOSPITAL CORP·Filed 2001·Granted May 9, 2006·2 cites·3 claims
- 0664US10494443B2LOX and LOXL2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2016·Granted Dec 3, 2019·0 cites·22 claims
- 0764US2014128284A1Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2013·Application pending·0 cites
- 0864US2014349309A1Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasisGILEAD BIOLOGICS INC·Filed 2014·Application pending·0 cites
- 0958US6225120B1Therapeutic and diagnostic tools for impaired glucose tolerance conditionsGEN HOSPITAL CORP·Filed 1997·Granted May 1, 2001·19 cites·6 claims
- 1058US2012087917A1Lox and loxl2 inhibitors and uses thereofSMITH VICTORIA·Filed 2011·Application pending·0 cites
- 1157US2016185877A1Lox and loxl2 inhibitors and uses thereofGILEAD BIOLOGICS INC·Filed 2015·Application pending·0 cites
- 1252US7414169B2Therapeutic and diagnostic tools for impaired glucose tolerance conditionsGEN HOSPITAL CORP·Filed 2001·Granted Aug 19, 2008·0 cites·5 claims
- 1346US11814679B2Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of sameLILLY CO ELI·Filed 2017·Granted Nov 14, 2023·0 cites·13 claims
- 1445US6861256B2Therapeutic and diagnostic tools for impaired glucose tolerance conditionsGEN HOSPITAL CORP·Filed 1998·Granted Mar 1, 2005·5 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Scott Ogg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →